© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Practical Management of Early Stage HER2+ Breast Cancer
September 29, 2020
Staff
Staff
Nurse practitioners provide insight on issues surrounding the administration of dual HER2-targeted therapy in the neoadjuvant/adjuvant setting and counseling patients on common AEs associated with trastuzumab-pertuzumab for the treatment of HER2+ breast cancer.
Related Content: